To further elucidate the role of CD98 in leukemogenesis, Bajaj and colleagues removed CD98 from mouse models of AML, increasing the survival of AML mice, while the proliferative and self-renewal abilities of normal hematopoietic stem cells (HSCs) were reduced in non-tumor mice. This evidence concerns the gene SLC3A2 and acute myeloid leukemia.